EU Compassionate Use Programmes (CUPs): Regulatory Framework and Points to Consider before CUP Implementation

Author： Sou Hélène  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.24, Iss.4, 2010-08, pp. : 223-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Global regulatory registration requirements for collagen-based combination products: points to consider

By O'Grady J.E.   Bordon D.M.  

Advanced Drug Delivery Reviews, Vol. 55, Iss. 12, 2003-11 ,pp. : 1699-1721

Elsevier

Access to resources Recommend Favorite

Dietary supplement use and the US regulatory framework

By  

Reactions Weekly, Vol. 1, Iss. 1018, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Dietary supplement use and the US regulatory framework

By  

Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Attorneys Aim to Reform “Compassionate Use”

By Printz Carrie  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 163-164

Blackwell Publishing

Access to resources Recommend Favorite

Consider more health and productivity outcomes in DM programmes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite